September 29, 2025 - Regulatory Proposal for a resolution on authorization for the Board of Directors to resolve on acquisition and transfer of own shares
July 15, 2025 - Regulatory Correction: SynAct to receive SEK 17.7 million after conversion of warrants
June 4, 2025 - Regulatory SynAct Pharma AB carries out a directed share issue of SEK 37 million and extends its financial runway to end of 2026
June 3, 2025 - Regulatory SynAct Pharma takes out a credit facility of SEK 30 million that extends the company’s financial runway to mid-2026, which strongly strengthens partnership opportunities.
February 20, 2025 - Regulatory SynAct’s Nomination Committee proposes Jeppe Ragnar Andersen to the Board
